A former DEA opioid investigator testified as Baltimore’s first expert witness in its civil trial against a pair of drug ...

We recently compiled a list of 10 Best Stocks To Buy Right Now According To Billionaire Cliff Asness. In this article, we ...

Two drug distribution companies at one point controlled 60% of the prescription opioid market in the Baltimore area, sending ...

Today, Benzinga's options scanner identified 12 options transactions for McKesson. This is an unusual occurrence. The ...

Robert W. Baird analyst Eric Coldwell downgraded the rating on McKesson (MCK – Research Report) to a Hold today, setting a price target of $531.00. Eric Coldwell’s rating is based on a series ...

McKesson declined about 20% in the last few weeks and sentiment suddenly turned. Of course, McKesson is performing hand-in-hand with the overall market and we can expect that McKesson will ...

There’s no reasonable explanation that I can imagine that would explain this amount in a city the size of Baltimore,” a ...

McKesson was founded in 1833 ... government's centralized distributor of COVID-19 vaccines during the pandemic. In order to improve the value for its customers and shareholders, it uses methods ...

McKesson denied the allegations in a $37 million ... it wasn’t clear whether any of the planned executions would happen. A judge’s order forbidding the use of an execution drug came on an ...

Deutsche Bank analyst George Hill maintained a Buy rating on McKesson (MCK – Research Report) today and set a price target of $579.00. George Hill has given his Buy rating due to a combination ...

McKesson has signed an agreement to sell its Canada-based Rexall and Well.ca businesses to Birch Hill Equity Partners, a Canadian private equity firm. “This transaction marks an important ...